Sales. While the Bio-UV share was worth more than 5 Euros at the start of the year, it is now trading at 3 Euros… Among the explanations for this big decline, the last vintage proved to be a a little worse than expected. The growth in sales is not to blame as it amounted to +16% organically thanks to favorable developments internationally and the good performance of activity in ship ballast water. But if the Ebitda margin increased from 11.7% in 2021 to 13.7% in 2022, the new management team expected it higher…
This stock market news is reserved for subscribers Privileges
Test our stock market advice for €1, without obligation
I subscribe
Already subscribed? Log in
Discover Boursier.com services Privileges
Learn more